DGNS Targets Aggressive Growth in 2026 through Strategic Investments

Capital Expenditure Allocation for Digital Transformation

PT Diagnos Laboratorium Utama Tbk (DGNS) has announced plans to allocate Rp12 billion in capital expenditure (Capex) for 2026, focusing on strengthening laboratory infrastructure and digitalizing internal systems ¹

. This strategic investment is designed to support the company's ambitious growth targets and enhance service quality. The Capex allocation will be primarily directed towards laboratory equipment upgrades and digital system enhancements to improve operational efficiency ¹

Source 1

https://industri.kontan.co.id/news/perkuat-infrastruktur-laboratorium-digitalisasi-dgns-siapkan-capex-segini-di-2026

.

Aggressive Growth Targets for 2026

DGNS is targeting 16% revenue growth and 31% net profit increase for 2026 compared to the previous year ²

. This aggressive growth strategy is built on optimizing existing clinic utilization and expanding service reach. The company's management believes that organic growth through improved operational efficiency will be the key driver of these targets ²

Source 2

https://industri.kontan.co.id/news/diagnos-laboratorium-utama-dgns-targetkan-pertumbuhan-agresif-pada-2026

.

Strategic Focus Areas

The company's growth strategy for 2026 will focus on:

1. Laboratory infrastructure strengthening through modern equipment
2. Digital system implementation for enhanced operational efficiency
3. Organic growth through optimal utilization of existing facilities